Literature DB >> 15738502

Nicotine dependence and symptoms in schizophrenia: naturalistic study of complex interactions.

M Carmen Aguilar1, Manuel Gurpegui, Francisco J Diaz, Jose de Leon.   

Abstract

BACKGROUND: Smoking may have a beneficial effect on either schizophrenic symptoms or antipsychotic side-effects, but studies are hampered by the lack of control of confounding factors. AIMS: To explore the self-medication hypothesis in a large sample of stable out-patients with schizophrenia.
METHOD: Symptoms, assessed with the Positive and Negative Syndrome Scale (PANSS), and number of hospitalisations were compared in 250 out-patients with DSM-IV schizophrenia classified into three categories: highly dependent smokers, mildly dependent smokers and non-smokers. Log-linear analysis was used to control for potential confounding and interacting variables.
RESULTS: High PANSS total scores and positive symptoms were less frequent in mildly dependent smokers than in non-smokers or highly dependent smokers. The highly dependent smokers had the worst outcome.
CONCLUSIONS: The data do not generally support the self-medication hypothesis but rather suggest a complex interaction between nicotine dependence and nicotine dependence and schizophrenic symptoms.

Entities:  

Mesh:

Year:  2005        PMID: 15738502     DOI: 10.1192/bjp.186.3.215

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  24 in total

1.  Predictors of smoking severity in patients with schizophrenia and alcohol use disorders.

Authors:  Zsuzsa Szombathyne Meszaros; Jacqueline A Dimmock; Robert J Ploutz-Snyder; Ynesse Abdul-Malak; Luba Leontieva; Kelly Canfield; Steven L Batki
Journal:  Am J Addict       Date:  2011-07-18

Review 2.  Smoking in schizophrenic patients: A critique of the self-medication hypothesis.

Authors:  Francesca Manzella; Susan E Maloney; George T Taylor
Journal:  World J Psychiatry       Date:  2015-03-22

Review 3.  Targeting neuronal dysfunction in schizophrenia with nicotine: Evidence from neurophysiology to neuroimaging.

Authors:  Jason Smucny; Jason R Tregellas
Journal:  J Psychopharmacol       Date:  2017-04-26       Impact factor: 4.153

Review 4.  Movement disorders: neurodevelopment and neurobehavioural expression.

Authors:  T Archer; R J Beninger
Journal:  J Neural Transm (Vienna)       Date:  2006-10-06       Impact factor: 3.575

5.  Smoking and Serum Lipid Profiles in Schizophrenia.

Authors:  Hui-Mei An; Yun-Long Tan; Shu-Ping Tan; Jing Shi; Zhi-Ren Wang; Fu-De Yang; Xu-Feng Huang; Jair C Soars; Thomas R Kosten; Xiang-Yang Zhang
Journal:  Neurosci Bull       Date:  2016-03-28       Impact factor: 5.203

Review 6.  Nicotinic interactions with antipsychotic drugs, models of schizophrenia and impacts on cognitive function.

Authors:  Edward D Levin; Amir H Rezvani
Journal:  Biochem Pharmacol       Date:  2007-07-20       Impact factor: 5.858

7.  Smoking in schizophrenia: diagnostic specificity, symptom correlates, and illness severity.

Authors:  Roman Kotov; Lin T Guey; Evelyn J Bromet; Joseph E Schwartz
Journal:  Schizophr Bull       Date:  2008-06-17       Impact factor: 9.306

Review 8.  Nicotine and nicotinic system in hypoglutamatergic models of schizophrenia.

Authors:  Yousef Tizabi
Journal:  Neurotox Res       Date:  2007-12       Impact factor: 3.911

9.  Nicotine consumption and schizotypy in first-degree relatives of individuals with schizophrenia and non-psychiatric controls.

Authors:  Michelle L Esterberg; Erin M Jones; Michael T Compton; Elaine F Walker
Journal:  Schizophr Res       Date:  2007-09-25       Impact factor: 4.939

10.  Socio-demographic and clinical characteristics of heavy and non-heavy smokers among schizophrenia inpatients in a Chinese Han population.

Authors:  Xiang Yang Zhang; Da Chun Chen; Yun Long Tan; Mei Hong Xiu; Jingyi Cui; Li Hui; Fu De Yang; Thomas R Kosten
Journal:  Psychopharmacology (Berl)       Date:  2013-08-21       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.